Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Infection with antibiotic-resistant bacteria, such as vancomycin-resistant Enterococcus (VRE), is a dangerous and costly complication of broad-spectrum antibiotic therapy. How antibiotic-mediated elimination of commensal bacteria promotes infection by antibiotic-resistant bacteria is a fertile area for speculation with few defined mechanisms. Here we demonstrate that antibiotic treatment of mice notably downregulates intestinal expression of RegIIIgamma (also known as Reg3g), a secreted C-type lectin that kills Gram-positive bacteria, including VRE. Downregulation of RegIIIgamma markedly decreases in vivo killing of VRE in the intestine of antibiotic-treated mice. Stimulation of intestinal Toll-like receptor 4 by oral administration of lipopolysaccharide re-induces RegIIIgamma, thereby boosting innate immune resistance of antibiotic-treated mice against VRE. Compromised mucosal innate immune defence, as induced by broad-spectrum antibiotic therapy, can be corrected by selectively stimulating mucosal epithelial Toll-like receptors, providing a potential therapeutic approach to reduce colonization and infection by antibiotic-resistant microbes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Colonization resistance takes place through direct (not requiring host involvement) or indirect mechanisms (ultimately mediated by the host response, as mentioned above for the modulation of AMPs) [18, 19].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Systemic administration of TLR-5 agonist flagellin, or oral administration of TLR-4 agonist LPS, were shown to reinstate resistance to VRE or C. difficile in mice previously treated with antibiotics, through restoration of RegIII-γ production [18-20].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a defect that can be reverted by oral administration of LPS [18]”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
In the citing paper
“even short-term antibiotic treatment impairs its expression, rendering mice susceptible to vancomycin-resistant enterococcus (VRE) infection”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Symbiotic bacteria direct expression of an intestinal bactericidal lectin
Cash, H. L., Whitham, C. V., Behrendt, C. L., & Hooper, L. V. (2006) · Science · doi:10.1126/science.1127119 · Cited by 1,432
Kelly, C. P., Pothoulakis, C., & LaMont, J. T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300406 · Cited by 1,321
Epithelial NEMO links innate immunity to chronic intestinal inflammation
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C., Madison, B., et al. (2007) · Nature · doi:10.1038/nature05698 · Cited by 1,077
Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, N. N. I. S. (2000) · Infection Control & Hospital Epidemiology · doi:10.1086/501795 · Cited by 1,028
Angiogenins: a new class of microbicidal proteins involved in innate immunity
Hooper, L. V., Stappenbeck, T. S., Hong, C. V., & Gordon, J. I. (2003) · Nature Immunology · doi:10.1038/ni888 · Cited by 929
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869
Cario, E., Rosenberg, I. M., Brandwein, S. L., Beck, P. L., Reinecker, H.-C., & Podolsky, D. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.966 · Cited by 751
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., Hutton-Thomas, R. A., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432604 · Cited by 689
Pull, S. L., Doherty, J. M., Mills, J. C., Gordon, J. I., & Stappenbeck, T. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405979102 · Cited by 605
TLR Signaling in the Gut in Health and Disease
Abreu, M. T., Fukata, M., & Arditi, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4453 · Cited by 581
The Role of the Intestinal Tract as a Reservoir and Source for Transmission of Nosocomial Pathogens
Donskey, C. J. (2004) · Clinical Infectious Diseases · doi:10.1086/422002 · Cited by 424
Genomic and Metabolic Studies of the Impact of Probiotics on a Model Gut Symbiont and Host
Sonnenburg, J. L., Chen, C. T. L., & Gordon, J. I. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040413 · Cited by 422
Hornef, M. W., Frisan, T., Vandewalle, A., Normark, S., & Richter-Dahlfors, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011788 · Cited by 414
Brandl, K., Plitas, G., Schnabl, B., DeMatteo, R. P., & Pamer, E. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070563 · Cited by 385
Self-citationAntimicrobial resistance in gram-positive bacteria
Rice, L. B. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.220 · Cited by 381
Strategic Compartmentalization of Toll-Like Receptor 4 in the Mouse Gut
Ortega-Cava, C. F., Ishihara, S., Rumi, M. A. K., Kawashima, K., Ishimura, N., Kazumori, H., Udagawa, J., Kadowaki, Y., & Kinoshita, Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.3977 · Cited by 346
Emergence of Vancomycin-Resistant Enterococci
Rice, L. B. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010205 · Cited by 277
Managing Antibiotic Resistance
Wenzel, R. P., & Edmond, M. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432610 · Cited by 204
Evidence for the Translocation of Enterococcus faecalis across the Mouse Intestinal Tract
Wells, C. L., Jechorek, R. P., & Erlandsen, S. L. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.1.82 · Cited by 197
Laboratory guidelines for monitoring of antimicrobial drugs
Hammett‐Stabler, C. A., & Johns, T. E. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.5.1129 · Cited by 110
Wells, C. L., Jechorek, R. P., Maddaus, M. A., & Simmons, R. L. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.12.1769 · Cited by 69
Pultz, N. J., Stiefel, U., Subramanyan, S., Helfand, M. S., & Donskey, C. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/428090 · Cited by 67
Cash, H. L., Whitham, C. V., & Hooper, L. V. (2006) · Protein Expression and Purification · doi:10.1016/j.pep.2006.01.014 · Cited by 65
Innate immune recognition on the intestinal mucosa
Lotz, M. M., Ménard, S., & Hornef, M. W. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.03.010 · Cited by 51
Stiefel, U., Pultz, N. J., Helfand, M. S., & Donskey, C. J. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502408 · Cited by 43
Miyazaki, S., Fujikawa, T., Kobayashi, I., Matsumoto, T., Tateda, K., & Yamaguchi, K. (2001) · Journal of Medical Microbiology · doi:10.1099/0022-1317-50-8-695 · Cited by 21
Cited by
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
“…antimicrobial peptide RegIIIg not only contributes to maintenance of segregation between the microbiota and host epithelial cells, but also promotes protection against defined pathogens, such as vancomycin-resistant Enterococcus faecalis (Brandl et al., 2008; Vaishnava et al., 2008, 2011).”
BackgroundInduction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K. C., Santee, C. A., Lynch, S. V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.033 · Cited by 4,554
“Our results are also consistent with the report that a vancomycin-sensitive component of the commensal microbiota induces RegIIIg in the mouse small intestine, thus reducing colonization by VRE and enhancing killing of the pathogen (Brandl et al., 2008).”
ResultGut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
“prolong their colonization of the infected murine host (28).”
BackgroundThe rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776
“Pioneering work using mouse models of intestinal colonizatio”
MethodControl of pathogens and pathobionts by the gut microbiota
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013) · Nature Immunology · doi:10.1038/ni.2608 · Cited by 1,625
Metadata
- Authors
- Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo, R. P., & Pamer, E. G.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of California San Diego (US)
- Corresponding author
- Pamer, Eric G.
- Venue
- Nature
- Published
- 2008-08-24
- Volume
- 455
- Issue
- 7214
- Pages
- 804-807
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2663337
- OpenAlex
- W2093972125
- Cited by
- 631
- References
- 28
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 27 · 2023: 30 · 2022: 25 · 2021: 29 · 2020: 48 · 2019: 32 · 2018: 56 · 2017: 41 · 2016: 36 · 2015: 39 · 2014: 37 · 2013: 38 · 2012: 39
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Alexander von Humboldt-Stiftung
- National Institutes of Health (4r37ai039031-21)
- National Institute of Allergy and Infectious Diseases (AI42135, R01AI039031, R01AI080619, R37-AI039031, AI 39031, R01AI042135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Keywords
- vancomycin-resistant enterococci, antibiotic resistance, intestinal innate immunity, RegIIIγ, C-type lectin, broad-spectrum antibiotics, TLR4, lipopolysaccharide, mucosal epithelium, commensal bacteria, antibiotic-associated infection, Gram-positive bacteria
- MeSH terms
- Pancreatitis-Associated Proteins, Animals, Immunity, Innate, Intestinal Mucosa, Intestines, Lipopolysaccharides, Proteins, Vancomycin, Signal Transduction, Down-Regulation, Enterococcus, Vancomycin Resistance, Toll-Like Receptor 4, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.